India · Delayed Price · Currency is INR Bafna Pharmaceuticals Statistics
Total Valuation
BOM:532989 has a market cap or net worth of INR 9.51 billion. The enterprise value is 9.86 billion.
| Market Cap | 9.51B |
| Enterprise Value | 9.86B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 23.66M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | +5.63% |
| Owned by Insiders (%) | 4.97% |
| Owned by Institutions (%) | 4.36% |
| Float | 3.34M |
Valuation Ratios
The trailing PE ratio is 122.09.
| PE Ratio | 122.09 |
| Forward PE | n/a |
| PS Ratio | 6.67 |
| PB Ratio | 9.89 |
| P/TBV Ratio | 9.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 61.85 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 126.64 |
| EV / Sales | 6.92 |
| EV / EBITDA | 84.67 |
| EV / EBIT | 186.84 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 3.21 |
| Debt / FCF | -3.93 |
| Interest Coverage | 1.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.01% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.21M |
| Profits Per Employee | 229,676 |
| Employee Count | 339 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +137.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +137.57% |
| 50-Day Moving Average | 299.97 |
| 200-Day Moving Average | 185.09 |
| Relative Strength Index (RSI) | 86.91 |
| Average Volume (20 Days) | 3,985 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532989 had revenue of INR 1.43 billion and earned 77.86 million in profits. Earnings per share was 3.24.
| Revenue | 1.43B |
| Gross Profit | 450.12M |
| Operating Income | 52.77M |
| Pretax Income | 76.56M |
| Net Income | 77.86M |
| EBITDA | 116.46M |
| EBIT | 52.77M |
| Earnings Per Share (EPS) | 3.24 |
Balance Sheet
The company has 20.25 million in cash and 374.33 million in debt, with a net cash position of -354.09 million.
| Cash & Cash Equivalents | 20.25M |
| Total Debt | 374.33M |
| Net Cash | -354.09M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 961.50M |
| Book Value Per Share | 40.57 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 153.71 million and capital expenditures -249.03 million, giving a free cash flow of -95.32 million.
| Operating Cash Flow | 153.71M |
| Capital Expenditures | -249.03M |
| Depreciation & Amortization | 63.68M |
| Net Borrowing | 92.35M |
| Free Cash Flow | -95.32M |
| FCF Per Share | n/a |
Margins
Gross margin is 31.57%, with operating and profit margins of 3.70% and 5.46%.
| Gross Margin | 31.57% |
| Operating Margin | 3.70% |
| Pretax Margin | 5.37% |
| Profit Margin | 5.46% |
| EBITDA Margin | 8.17% |
| EBIT Margin | 3.70% |
| FCF Margin | n/a |
Dividends & Yields
BOM:532989 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.32% |
| Shareholder Yield | -1.32% |
| Earnings Yield | 0.82% |
| FCF Yield | -1.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |